These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 17897106

  • 1. Nephrogenic systemic fibrosis: a nephrologist's perspective.
    Saab G, Cheng S.
    Hemodial Int; 2007 Oct; 11 Suppl 3():S2-6. PubMed ID: 17897106
    [Abstract] [Full Text] [Related]

  • 2. Nephrogenic systemic fibrosis--implications for nephrologists.
    Saab G, Abu-Alfa A.
    Eur J Radiol; 2008 May; 66(2):208-12. PubMed ID: 18342470
    [Abstract] [Full Text] [Related]

  • 3. The impact of NSF on the care of patients with kidney disease.
    Abu-Alfa A.
    J Am Coll Radiol; 2008 Jan; 5(1):45-52. PubMed ID: 18180009
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.
    Peak AS, Sheller A.
    Ann Pharmacother; 2007 Sep; 41(9):1481-5. PubMed ID: 17684032
    [Abstract] [Full Text] [Related]

  • 5. Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure.
    Grobner T, Prischl FC.
    Semin Dial; 2008 Sep; 21(2):135-9. PubMed ID: 18226001
    [Abstract] [Full Text] [Related]

  • 6. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 7. Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.
    Todd DJ, Kagan A, Chibnik LB, Kay J.
    Arthritis Rheum; 2007 Oct 01; 56(10):3433-41. PubMed ID: 17907148
    [Abstract] [Full Text] [Related]

  • 8. Nephrogenic systemic fibrosis and its impact on abdominal imaging.
    Prince MR, Zhang HL, Prowda JC, Grossman ME, Silvers DN.
    Radiographics; 2009 Oct 01; 29(6):1565-74. PubMed ID: 19959508
    [Abstract] [Full Text] [Related]

  • 9. Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
    Abu-Alfa AK.
    Adv Chronic Kidney Dis; 2011 May 01; 18(3):188-98. PubMed ID: 21531325
    [Abstract] [Full Text] [Related]

  • 10. [Nephrogenic systemic fibrosis].
    Breitschaft A, Stahlmann R.
    Med Monatsschr Pharm; 2009 Oct 01; 32(10):377-82. PubMed ID: 19886227
    [Abstract] [Full Text] [Related]

  • 11. Nephrogenic system fibrosis: a radiologist's practical perspective.
    Martin DR.
    Eur J Radiol; 2008 May 01; 66(2):220-4. PubMed ID: 18321672
    [Abstract] [Full Text] [Related]

  • 12. [Nephrogenic systemic fibrosis after application of gadolinium-based contrast agents--a status paper].
    Heinrich M, Uder M.
    Rofo; 2007 Jun 01; 179(6):613-7. PubMed ID: 17497597
    [Abstract] [Full Text] [Related]

  • 13. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
    Kallen AJ, Jhung MA, Cheng S, Hess T, Turabelidze G, Abramova L, Arduino M, Guarner J, Pollack B, Saab G, Patel PR.
    Am J Kidney Dis; 2008 Jun 01; 51(6):966-75. PubMed ID: 18501784
    [Abstract] [Full Text] [Related]

  • 14. Dialytic therapies to prevent NSF following gadolinium exposure in high-risk patients.
    Rodby RA.
    Semin Dial; 2008 Jun 01; 21(2):145-9. PubMed ID: 18226002
    [Abstract] [Full Text] [Related]

  • 15. Nephrogenic systemic fibrosis and management of high-risk patients.
    Altun E, Semelka RC, Cakit C.
    Acad Radiol; 2009 Jul 01; 16(7):897-905. PubMed ID: 19375360
    [Abstract] [Full Text] [Related]

  • 16. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.
    Prasad SR, Jagirdar J.
    J Comput Assist Tomogr; 2008 Jul 01; 32(1):1-3. PubMed ID: 18303280
    [Abstract] [Full Text] [Related]

  • 17. [Nephrogenic systemic fibrosis and gadolinium-based contrast media].
    Andréjak M, Thuillier D, Lok C, Gras-Champel V.
    Therapie; 2007 Jul 01; 62(2):169-72. PubMed ID: 17582319
    [Abstract] [Full Text] [Related]

  • 18. [Nephrogenic systemic fibrosis].
    Cavallini L, Abaterusso C, Bedogna V, Pertica N, Loschiavo C, Lupo A.
    G Ital Nefrol; 2008 Jul 01; 25(1):14-20. PubMed ID: 18264914
    [Abstract] [Full Text] [Related]

  • 19. Nephrogenic systemic fibrosis: recommendations for gadolinium-based contrast use in patients with kidney disease.
    Perazella MA, Reilly RF.
    Semin Dial; 2008 Jul 01; 21(2):171-3. PubMed ID: 18226005
    [Abstract] [Full Text] [Related]

  • 20. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
    Othersen JB, Maize JC, Woolson RF, Budisavljevic MN.
    Nephrol Dial Transplant; 2007 Nov 01; 22(11):3179-85. PubMed ID: 17890246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.